Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Journal of Pharmaceutical Sciences|September 20, 2007
Rapid throughput screening of apparent KSP values for weakly basic drugs using 96-well formatJeremy Guo, Paul A Elzinga, Michael J Hageman, et al.Journal of Pharmaceutical Sciences|August 29, 2007
Rapid throughput solubility screening method for BCS class II drugs in animal GI fluids and simulated human GI fluids using a 96-well formatJeremy Guo, Paul A Elzinga, Michael J Hageman, et al.Bioorganic & Medicinal Chemistry Letters|August 28, 2022
The discovery of BMS-737 as a potent, CYP17 lyase-selective inhibitor for the treatment of castration-resistant prostate cancerChetan Padmakar Darne, Upender Velaparthi, Mark Saulnier, et al.ACS Medicinal Chemistry Letters|January 29, 2016
Discovery of the Selective CYP17A1 Lyase Inhibitor BMS-351 for the Treatment of Prostate CancerAudris Huang, Lata Jayaraman, Aberra Fura, et al.Journal of Medicinal Chemistry|December 28, 2020
Discovery of BMS-986202: A Clinical Tyk2 Inhibitor that Binds to Tyk2 JH2Chunjian Liu, James Lin, Charles Langevine, et al.Journal of Medicinal Chemistry|March 21, 2019
Discovery of Branebrutinib (BMS-986195): A Strategy for Identifying a Highly Potent and Selective Covalent Inhibitor Providing Rapid in Vivo Inactivation of Bruton's Tyrosine Kinase (BTK)Scott H Watterson, Qingjie Liu, Myra Beaudoin Bertrand, et al.Pageof 1